Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 66987 [E9-30023]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
submissions may be made to the contact
person on or before January 27, 2010.
Oral presentations from the public will
be scheduled between approximately
10:30 a.m. to 11 a.m., and 3:30 p.m. to
4 p.m. Those desiring to make formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before January 19, 2010. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
January 20, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Nicole
Vesely at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: December 11, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–29989 Filed 12–16–09; 8:45 am]
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the twenty-first
meeting of the Secretary’s Advisory
VerDate Nov<24>2008
13:19 Dec 16, 2009
Jkt 220001
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to approximately 5:30 p.m. on
Thursday, February 4, 2010, and from 8
a.m. to approximately 3 p.m. on Friday,
February 5, 2010, at the Omni Shoreham
Hotel, 2500 Calvert Street, NW.,
Washington, DC 20008. The meeting
will be open to the public with
attendance limited to space available.
The meeting also will be Web cast.
The main agenda items involve the
review of a revised report on gene
patents and licensing practices, the
review of a public consultation draft
report on genetics education and
training, and an information-gathering
session on the mechanisms and policies
related to genomic data sharing. Other
agenda items include a preliminary
discussion to help plan a future session
on implications of an affordable
genome; a report on activities of the
Clinical Utility and Comparative
Effectiveness Task Force; and updates
from Federal agencies on activities
related to the implementation of the
Genetic Information Nondiscrimination
Act, the coverage and reimbursement of
genetic tests, the oversight of genetic
testing, and the retention and use of
residual dried blood spot specimens
after newborn screening.
As always, the Committee welcomes
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health, and society.
Individuals who would like to provide
public comment should notify the
SACGHS Executive Secretary, Ms. Sarah
Carr, by telephone at 301–496–9838 or
e-mail at carrs@od.nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting who needs special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
oba.od.nih.gov/SACGHS/
sacghs_meetings.html.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
66987
Dated: December 10, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory
Committee Policy.
[FR Doc. E9–30023 Filed 12–16–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Transplant and Viruses.
Date: January 11, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call.)
Contact Person: Priti Mehrotra, PhD, Chief,
Immunology Review Branch, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
6700B Rockledge Drive, Room 3138,
Bethesda, MD 20892–7616, 301–435–9369,
pm158b@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, ‘‘B Lymphocyte Responses.’’
Date: January 12, 2010.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call.)
Contact Person: Wendy F. Davidson, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIH/NIAID/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–8399, davidsonw@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\17DEN1.SGM
17DEN1
]]>Agencies
[Federal Register Volume 74, Number 241 (Thursday, December 17, 2009)]
[Notices]
[Page 66987]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30023]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the
twenty-first meeting of the Secretary's Advisory Committee on Genetics,
Health, and Society (SACGHS), U.S. Public Health Service. The meeting
will be held from 8:30 a.m. to approximately 5:30 p.m. on Thursday,
February 4, 2010, and from 8 a.m. to approximately 3 p.m. on Friday,
February 5, 2010, at the Omni Shoreham Hotel, 2500 Calvert Street, NW.,
Washington, DC 20008. The meeting will be open to the public with
attendance limited to space available. The meeting also will be Web
cast.
The main agenda items involve the review of a revised report on
gene patents and licensing practices, the review of a public
consultation draft report on genetics education and training, and an
information-gathering session on the mechanisms and policies related to
genomic data sharing. Other agenda items include a preliminary
discussion to help plan a future session on implications of an
affordable genome; a report on activities of the Clinical Utility and
Comparative Effectiveness Task Force; and updates from Federal agencies
on activities related to the implementation of the Genetic Information
Nondiscrimination Act, the coverage and reimbursement of genetic tests,
the oversight of genetic testing, and the retention and use of residual
dried blood spot specimens after newborn screening.
As always, the Committee welcomes hearing from anyone wishing to
provide public comment on any issue related to genetics, health, and
society. Individuals who would like to provide public comment should
notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at
301-496-9838 or e-mail at carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone
planning to attend the meeting who needs special assistance, such as
sign language interpretation or other reasonable accommodations, is
also asked to contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic and genomic technologies and, as
warranted, to provide advice on these issues. The draft meeting agenda
and other information about SACGHS, including information about access
to the Web cast, will be available at the following Web site: https://oba.od.nih.gov/SACGHS/sacghs_meetings.html.
Dated: December 10, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory Committee Policy.
[FR Doc. E9-30023 Filed 12-16-09; 8:45 am]
BILLING CODE 4140-01-P
